Defunct Company
Total Trials
15
As Lead Sponsor
13
As Collaborator
2
Total Enrollment
6,516
NCT00733876
Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 31, 2008
Completion: Oct 31, 2013
NCT01413061
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
Phase: N/A
Start: Jun 30, 2010
Completion: Mar 31, 2018
NCT01602328
A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects
Phase: Phase 2
Start: Jun 30, 2012
Completion: Aug 31, 2014
NCT03530826
A Crowd Sourcing Platform for Patients With Cancer
Start: Apr 26, 2018
Completion: Jan 31, 2028
NCT03873545
Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella
Start: Mar 18, 2019
Completion: Dec 30, 2028
NCT04301258
ProChondrix® CR Articular Cartilage Restoration Evaluation (PACE) Registry
Start: Jan 6, 2020
Completion: Sep 14, 2023
NCT04684901
Effectiveness of AlloWrap® for the Reduction of Inflammation in ACDF Procedures
Start: Jan 18, 2021
Completion: Jan 31, 2026
NCT04162639
The Relationship Between Cadaveric Allograft Skin and HLA-Sensitivity in Burn Patients
Phase: Phase 4
Role: Collaborator
Start: Feb 28, 2021
Completion: Feb 28, 2023
NCT04615117
An Outcomes Study Utilizing Allomend(R) HD for Superior Capsular Reconstruction
Start: Aug 1, 2021
Completion: Dec 31, 2025
NCT05673083
Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
Start: Mar 1, 2023
Completion: Mar 31, 2026
NCT05744414
Histological Analysis of AlloMend® Acellular Dermal Matrix Used in Breast Implant Surgeries
Start: May 17, 2023
NCT06512259
AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction
Start: Oct 19, 2023
NCT06149910
Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma
Start: Apr 18, 2024
Completion: Dec 1, 2026
NCT06216756
Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee
Start: Dec 1, 2024
Completion: Mar 31, 2031
NCT06853964
Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction
Start: Jan 27, 2025